Polycaprolactone thin-film drug delivery systems: Empirical and predictive models for device design.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 26354259)

Published in Mater Sci Eng C Mater Biol Appl on August 01, 2015

Authors

Erica Schlesinger1, Natalie Ciaccio2, Tejal A Desai3

Author Affiliations

1: University of California, Berkeley-University of California San Francisco Graduate Program in Bioengineering, CA, USA.
2: Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA; BioMarin Pharmaceutical Inc., Novato, CA, USA.
3: University of California, Berkeley-University of California San Francisco Graduate Program in Bioengineering, CA, USA; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA.

Articles cited by this

DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res (2007) 13.94

Effectiveness of long-acting reversible contraception. N Engl J Med (2012) 5.45

Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS (2013) 1.73

Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev (2001) 1.71

Building drug delivery into tissue engineering. Nat Rev Drug Discov (2002) 1.32

Modeling of diffusion controlled drug delivery. J Control Release (2011) 1.20

PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm (2007) 1.13

Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials (2005) 1.09

Nanostructured thin film polymer devices for constant-rate protein delivery. Nano Lett (2012) 0.96

Nanochannel technology for constant delivery of chemotherapeutics: beyond metronomic administration. Pharm Res (2010) 0.94

Anomalous release of hydrophilic drugs from poly(epsilon-caprolactone) matrices. Mol Pharm (2007) 0.87

Sustained drug delivery in glaucoma. Curr Opin Ophthalmol (2014) 0.86

Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy. J Ocul Pharmacol Ther (2012) 0.83

The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol. Mol Pharm (2014) 0.83

Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms. J Med Chem (2007) 0.83